CST showing some promise at last while PGL is in the fast lane.CST is waiting for the FDA and Japanese regulatory approvals.From CST, Oct8: "We are advised to expect further communication from the FDA within thenext two weeks". Background:CST:http://www.hotcopper.com.au/post_thread.asp?fid=1&tid=113028#311493PGL:http://www.hotcopper.com.au/post_thread.asp?fid=1&tid=104816#287956GerryReaders, please do your own research and you decide if and when to buy, hold or sell any stocks. To visit archived posts, please use the Search button
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
